Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

Payam Tabarsi; Nassim Anjidani; Ramin Shahpari; Masoud Mardani; Araz Sabzvari; Babak Yazdani; Khashayar Roshanzamir; Behnam Bayatani; Ali Taheri; Nikolai Petrovsky; Lei Li; Saghar Barati

Clinical Microbiology and Infection (2022) - Comments
pubmed: 35436611 doi: 10.1016/j.cmi.2022.04.004 issn: 1198-743x issn: 1469-0691

Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Masoud Mardani, Araz Sabzvari, Babak Yazdani, Khashayar Roshanzamir, Behnam Bayatani, Ali Taheri, Nikolai Petrovsky, Lei Li, Saghar Barati